logo

For the Inventor, By the Inventor

Beerse, Belgium

Janssen Pharmaceutica Nv


USPTO Granted Patents = 2,078



Trademarks = 2

Forward Citations = 11,498

Loading Chart...
Loading Chart...

1,901 inventors (with patents filed for the assignee):

goldMedal Jan Heeres (102 out of 124 patents)

silverMedal Lieven Meerpoel (84 out of 97 patents)

bronzeMedal Zhihua Sui (78 out of 108 patents)

4.  Mark J Macielag (74 out of 90 patents)

5.  James Patrick Edwards (73 out of 165 patents)

6.  Frans E Janssens (70 out of 77 patents)

7.  Kristof Van Emelen (50 out of 50 patents)

8.  Patrick René Angibaud (49 out of 65 patents)

9.  Marc Gaston Venet (49 out of 54 patents)

10.  Peter J Connolly (48 out of 70 patents)

11.  Yue-Mei Zhang (48 out of 49 patents)

12.  Michael Anthony Letavic (45 out of 65 patents)

13.  Curt A Dvorak (44 out of 49 patents)

14.  Aihua Wang (43 out of 51 patents)

15.  Neelakandha S Mani (43 out of 48 patents)


Core Competencies:
Btk Inhibitors
Neurological Disorders
Prostate Cancer Treatments
Orexin Receptor Modulators
JAK Family Kinases
Cholangiocarcinoma
Cognitive Decline Detection
IL-17 Inhibitor Compounds
AMPA Receptor Modulators
Intranasal Drug Delivery
Anti-VISTA Antibodies
Long-Acting Formulations

2,078 patents:

1. 12502378 - Monoacylglycerol lipase modulators for use in autism spectrum disorders (2025-12-23),
2. 12492194 - HPK1 inhibitors (2025-12-09),
3. 12486264 - Bicyclic HPK1 inhibitors (2025-12-02),
4. 12472184 - Dosing regimens associated with extended release paliperidone injectable formulations (2025-11-18),
5. 12459948 - Processes and intermediates for preparing a Btk inhibitor (2025-11-04),
6. 12441801 - Anti-VISTA antibodies and fragments, uses thereof, and methods of identifying same (2025-10-14),
7. 12433880 - Methods for the treatment of neurological disorders (2025-10-07),
8. 12404260 - Pyridine rings containing derivatives as MALT1 inhibitors (2025-09-02),
9. 12398155 - Thienopyridinone compounds (2025-08-26),
10. 12390451 - Small molecule inhibitor of the JAK family of kinases (2025-08-19),
11. 12383635 - Radiolabelled MGL PET ligands (2025-08-12),
12. 12383543 - Methods of treating prostate cancer (2025-08-12),
13. 12378254 - Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators (2025-08-05),
14. 12378246 - Synthetic options towards the manufacture of (6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6H)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one (2025-08-05),
15. D1086441 - Intranasal drug delivery device (2025-07-29),
Janssen Pharmaceutica NV is a global pharmaceutical company that specializes in the research, development, and production of innovative medicines, treatments, and healthcare solutions. With a focus on delivering transformative therapies to improve the health and well-being of people worldwide, Janssen Pharmaceutica NV is committed to advancing healthcare through scientific advancements and partnerships. Visit their website for more information on their products, research, and corporate initiatives.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
2,078 Patents

#1 in Beerse

#1 in Belgium

#470 in the World

...
Beerse, Belgium

Janssen Pharmaceutica Nv

Forward Citations = 11,498

1,901 inventors:

goldMedal Jan Heeres (102 out of 124 patents)

silverMedal Lieven Meerpoel (84 out of 97 patents)

bronzeMedal Zhihua Sui (78 out of 108 patents)

4.  Mark J Macielag (74 out of 90 patents)

5.  James Patrick Edwards (73 out of 165 patents)

Please report any incorrect information to support@idiyas.com
Loading…